Drug Patent Expirations for Dec 1, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

BYDUREON (exenatide synthetic)
Astrazeneca Ab
Patent number: 5,424,286
Expiration Date: Dec 1, 2016

BYDUREON PEN (exenatide synthetic)
Astrazeneca Ab
Patent number: 5,424,286
Expiration Date: Dec 1, 2016

BYETTA (exenatide synthetic)
Astrazeneca Ab
Patent number: 5,424,286
Expiration Date: Dec 1, 2016

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial

Click here for reuse options!
Copyright 2016 Biotechblog

Leave a Reply

%d bloggers like this: